Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986–90) and in the nationwide immunisation program

A million africans a year dying from cancer by 2030: What can cancer research and control offer to the continent?

(2011) Bakary S. Sylla et al.   INTERNATIONAL JOURNAL OF CANCER

The worldwide impact of vaccination on the control and protection of viral hepatitis B

(2010) Luisa Romano' et al.   DIGESTIVE AND LIVER DISEASE

Seroprevalence of markers for hepatitis B viral infection

(2010) Ray M. Merrill et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Loss of antibodies, but not of protection

(2010) Jürgen J Wenzel et al.   LANCET INFECTIOUS DISEASES

Hepatitis B virus infection

(2009) Yun-Fan Liaw et al.   LANCET

Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis

(2009) Jalal Poorolajal et al.   VACCINE

20 Years into the Gambia Hepatitis Intervention Study: Assessment of Initial Hypotheses and Prospects for Evaluation of Protective Effectiveness Against Liver Cancer

(2008) S. Viviani et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Part I: Cancer in Indigenous Africans—burden, distribution, and trends

(2008) D Max Parkin et al.   LANCET ONCOLOGY

The global impact of vaccination against hepatitis B: A historical overview

(2008) Alessandro R. Zanetti et al.   VACCINE